CL2020001063A1 - High purity copper molecule procedure and products for therapeutic use - Google Patents

High purity copper molecule procedure and products for therapeutic use

Info

Publication number
CL2020001063A1
CL2020001063A1 CL2020001063A CL2020001063A CL2020001063A1 CL 2020001063 A1 CL2020001063 A1 CL 2020001063A1 CL 2020001063 A CL2020001063 A CL 2020001063A CL 2020001063 A CL2020001063 A CL 2020001063A CL 2020001063 A1 CL2020001063 A1 CL 2020001063A1
Authority
CL
Chile
Prior art keywords
skin
composition
treatment
products
addition
Prior art date
Application number
CL2020001063A
Other languages
Spanish (es)
Inventor
Denis Hidalgo Carrasco Alejandro
Original Assignee
Denis Hidalgo Carrasco Alejandro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denis Hidalgo Carrasco Alejandro filed Critical Denis Hidalgo Carrasco Alejandro
Priority to CL2020001063A priority Critical patent/CL2020001063A1/en
Publication of CL2020001063A1 publication Critical patent/CL2020001063A1/en
Priority to PCT/CL2021/050030 priority patent/WO2021212246A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16—Heavy metals; Compounds thereof
    • A01N59/20—Copper
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25C—PROCESSES FOR THE ELECTROLYTIC PRODUCTION, RECOVERY OR REFINING OF METALS; APPARATUS THEREFOR
    • C25C1/00—Electrolytic production, recovery or refining of metals by electrolysis of solutions
    • C25C1/12—Electrolytic production, recovery or refining of metals by electrolysis of solutions of copper
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P10/00—Technologies related to metal processing
    • Y02P10/20—Recycling

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dentistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Electrochemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición de cobre molecular de composición Cu + 2 + e2 = Cu(s) al 99,998% de pureza diluida en agua bidestilada o desmineralizada, homogenizado con ondas de ultrasonido obtenido por un procedimiento físico - químico de electrolisis realizado en un recipiente de vidrio de volumen variable. La composición descrita, aplicada sobre la piel de manera tópica o mediante su ingesta oral, presenta propiedades analgésicas, antiinflamatorias, antivirales (incluido Covid-19), anifungicas y antibioticas, siendo, además, útil para el tratamiento de úlceras, quemaduras de piel, enfermedad de epidermólisis ampollar (piel de cristal), enfermedades de la memoria descriptiva y enfermedades neurológicas degenerativas, además de servir para el tratamiento de todo tipo de condiciones caracterizadas por una alta presencia de dolor, con propiedades cicatrizantes, productoras de colágeno y regeneradoras de la piel.Molecular copper composition with Cu + 2 + e2 = Cu (s) composition at 99.998% purity diluted in double distilled or demineralized water, homogenized with ultrasound waves obtained by a physical-chemical electrolysis procedure carried out in a volume glass container variable. The described composition, applied to the skin topically or by oral intake, has analgesic, anti-inflammatory, antiviral (including Covid-19), antifungal and antibiotic properties, being, in addition, useful for the treatment of ulcers, skin burns, Epidermolysis bullous disease (crystal skin), descriptive memory diseases and degenerative neurological diseases, in addition to serving for the treatment of all kinds of conditions characterized by a high presence of pain, with healing, collagen-producing and regenerative properties of the skin.

CL2020001063A 2020-04-20 2020-04-20 High purity copper molecule procedure and products for therapeutic use CL2020001063A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2020001063A CL2020001063A1 (en) 2020-04-20 2020-04-20 High purity copper molecule procedure and products for therapeutic use
PCT/CL2021/050030 WO2021212246A1 (en) 2020-04-20 2021-04-19 High-purity copper molecule method and products for therapeutic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2020001063A CL2020001063A1 (en) 2020-04-20 2020-04-20 High purity copper molecule procedure and products for therapeutic use

Publications (1)

Publication Number Publication Date
CL2020001063A1 true CL2020001063A1 (en) 2020-10-30

Family

ID=73047996

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020001063A CL2020001063A1 (en) 2020-04-20 2020-04-20 High purity copper molecule procedure and products for therapeutic use

Country Status (2)

Country Link
CL (1) CL2020001063A1 (en)
WO (1) WO2021212246A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8097132B2 (en) * 2006-07-04 2012-01-17 Luis Antonio Canales Miranda Process and device to obtain metal in powder, sheet or cathode from any metal containing material
WO2011140128A2 (en) * 2010-05-03 2011-11-10 Spenco Medical Corporation Nail discoloration and fungus treatment
CL2013002637A1 (en) * 2013-09-12 2014-02-21 Nanotec S A Quick-drying gel type disinfectant composition that does not contain toxic bactericides, which comprises a gelling agent, surfactant, carboxyvinyl polymer and an amide as a bactericide containing nanometallic copper and demineralized water.
CN109306405B (en) * 2018-10-29 2020-04-21 河南国玺超纯新材料股份有限公司 Method for industrially producing 6N ultra-pure copper
CN109252190B (en) * 2018-11-07 2021-02-02 广州市吉池环保科技有限公司 Method for recovering 99.98% copper powder from etching solution and preparing 99.999% cathode copper

Also Published As

Publication number Publication date
WO2021212246A1 (en) 2021-10-28

Similar Documents

Publication Publication Date Title
US20100003311A1 (en) Antimicrobial Composition
CN106309471A (en) Applications and preparation of low-molecular-weight biological active hyaluronic acid
ES2970227T3 (en) Compositions for the treatment of epithelial lesions
ES2635169T3 (en) Tamarind seed polysaccharide and Ferula hermonis extract for use in the treatment of inflammatory diseases
Ali et al. Propolis buccal paste in treatment of aphthous ulceration: formulation and clinical evaluation
CL2020001063A1 (en) High purity copper molecule procedure and products for therapeutic use
WO2016029328A1 (en) Pharmaceutical composition for preventing, treating, and curing psoriasis including snail slime, chamomile, and honey
US20080058283A1 (en) Composition based on salts of hyaluronic acid for treating epithelial lesions
ES2703530T3 (en) Healing composition and use
JP2008508354A5 (en)
ES2377612A1 (en) Use of crassula for treating proliferative diseases
Syed et al. Topical treatment of penile condylomata acuminata with podophyllotoxin 0.3% solution, 0.3% cream and 0.15% cream: A comparative open study
DE60305962T2 (en) USE OF A DISTRONTIUM SALT OF 2-iN, N-DI (CARBOXYMETHYL) AMINO-3-CYANO-4-CARBOXYMETHYL-THIOPHENE-5-CARBOXYLIC ACID FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GASTRODUODENAL PAIN
ES2549045T3 (en) Method for treating a herpes virus infection using a macrocyclic lactone compound
CH691030A5 (en) A gel formulation, for topical use in the pharmaceutical, cosmetic, dietetic and veterinary industries
Bakshi et al. Pyogenic granuloma of the hard palate: a case report and review of the literature.
BR112020025302A2 (en) INCREASE ANTIBACTERIAL ACTIONS OF A DEPSIPEPTIDIC ANTIBIOTIC USING SYNERGIC QUANTITIES OF BORIC ACID
Scholar CLINICAL STUDY ON THE EFFICACY OF DASHAMULA KWATHA AS AN ANALGESIC IN SUTIKA AWASTHA SHULA
EA005132B1 (en) Medical preparation
JPH08502018A (en) Medical use of trioxolane and diperoxide compounds
RU2604128C1 (en) Preparation for treating periodontitis
Sarkisyan et al. Antimicrobial peptides in the treatment of muscular oral cavity
Rajagopalan et al. Vaginal colonisation by Candida lipolytica.
Bilovol et al. Dermatology. Venereology. Part 3
De Souza et al. EPIDEMIOLOGICAL PROFILE OF PATIENTS DIAGNOSED WITH ORAL CARCINOMA: HAS THE DISEASE BEEN AFFECTING YOUNGER PATIENTS?